Clinical Trials Logo

Filter by:
NCT ID: NCT01154205 Not yet recruiting - Clinical trials for Clinical Workload Assessment Based Upon a Home Monitoring System

Sheba Medical Center Home Monitoring Clinic Registry

Start date: June 2010
Phase: N/A
Study type: Observational

The purpose of the registry is to assess workload of a Home Monitoring based follow up for Biotronik ICD and CRTD patients.

NCT ID: NCT01153945 Withdrawn - Thyroid Cancer Clinical Trials

Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum

Start date: February 2011
Phase: N/A
Study type: Observational

Much experimental data has suggested that thyroid hormones (T3 and T4) may modulate neoplastic cells and that T3/T4 deprivation may remove this stimulus. It is now well established that T3/T4 affects cell division/angiogenesis through binding to integrin avb3, commonly over-expressed on many cancer cells. In the experimental settings, mimicking hypothyroidism in the cells is a difficult task. Currently, the use of charcoal stripped serum is used. Using this method, the serum is stripped not only from T3 and T4, as intended, but also from central and important cytokines and growth factor. This leads to a reduced rate of cancer cell proliferation and thus, does not reflect the natural environment in which cancer cells residue under hypothyroid conditions. The investigators aim to characterize and establish the effects of serum from hypothyroid patients on the proliferation/viability of a variety of cancer cell models.

NCT ID: NCT01153932 Completed - Clinical trials for Muscular Dystrophies

Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy

Start date: September 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether GSK2402968 given as a continuous dose and as an intermittent dose is effective and safe in the treatment of Duchenne muscular dystrophy.

NCT ID: NCT01152983 Not yet recruiting - Healthy Clinical Trials

Safety and Performance Evaluation of the Rapid Ring Device

Start date: August 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to demonstrate the safety, performance and initial efficacy of the RapiDx device.

NCT ID: NCT01152658 Withdrawn - Clinical trials for Partial Supraspinatus Tear

Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)

PrgfRC001IL
Start date: April 2010
Phase: Phase 1
Study type: Interventional

The objective of this clinical trial is to evaluate the impact and symptomatic efficacy of platelets rich plasma (PRP \ PRGF) in the treatment of partial tears of supraspinatus tendon of rotator cuff. Speed of tendon healing of partial thickness tear of the supraspinatus tendon influenced by local injection of platelets rich plasma

NCT ID: NCT01152593 Not yet recruiting - Cesarean Section Clinical Trials

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Start date: July 2010
Phase: N/A
Study type: Interventional

The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

NCT ID: NCT01152528 Not yet recruiting - Preterm Birth Clinical Trials

Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery

Start date: July 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether screening of pregnant women with history of previous preterm delivery, once a week, for bacterial vaginosis using VA-SENSE, and treatment of positive women will reduce the risk of spontaneous preterm birth. We will compare between the effectiveness of once a week screening and once during pregnancy screening.

NCT ID: NCT01151423 Completed - Clinical trials for Acquired Thrombotic Thrombocytopenic Purpura

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

TITAN
Start date: January 2011
Phase: Phase 2
Study type: Interventional

This study was a Phase II, single-blind, randomized, placebo-controlled trial to determine whether anti-vWF Nanobody is safe and effective as adjunctive treatment in patients with aTTP. Patients received either placebo or anti-vWF Nanobody as adjunctive therapy to plasma exchange (PE).

NCT ID: NCT01151397 Not yet recruiting - Chronic Hepatitis C Clinical Trials

Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?

Start date: August 2011
Phase: N/A
Study type: Interventional

Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combination therapy obtaining sustained virologic response (SVR) in 80% of naïve patients with genotype 2,3. Studies rarely address the issues of improving host factors. The current study examines 1. Does 3 months therapy with Vitamin D+ Peg + Ribavirin could improve viral response and shorten treatment duration (from 24 weeks to 12 weeks) 2. whether Vitamin D levels predicts negative treatment outcome.

NCT ID: NCT01151163 Recruiting - Fibromyalgia Clinical Trials

Peripheral Arterial Tonometry (PAT) Evaluation of Sleep in Fibromyalgia

Start date: January 2011
Phase: N/A
Study type: Observational

Fibromyalgia syndrome (FMS) is characterized by the presence of widespread pain, chronic fatigue and typical sleep disturbances. The purpose of the current study is to investigate the nature of sleep disturbance in FMS, using a novel technology. Peripheral arterial tonometry is a method by which peripheral arterial tone is measured non - invasively using in an ambulatory setup during sleep. The information collected reflects autonomic nervous system function and respiratory changes during sleep. We intend to utilize this technique in order to improve our understanding of the interrupted patterns of sleep in FMS and as a possible biomarker which may be used in the future to follow up FMS patients and their response to treatment.